Dexmedetomidine and meperidine additively reduce the shivering threshold in humans.
Anthony G Doufas, Chun-Ming Lin, Mohammad-Irfan Suleman, Edwin B Liem, Rainer Lenhardt, Nobutada Morioka, Ozan Akça, Yunus M Shah, Andrew R Bjorksten, Daniel I Sessler
Stroke | Published : 2003
BACKGROUND AND PURPOSE: Hypothermia might prove to be therapeutically beneficial in stroke victims; however, even mild hypothermia provokes vigorous shivering. Meperidine and dexmedetomidine each linearly reduce the shivering threshold (triggering core temperature) with minimal sedation. We tested the hypothesis that meperidine and dexmedetomidine synergistically reduce the shivering threshold without producing substantial sedation or respiratory depression. METHODS: We studied 10 healthy male volunteers (18 to 40 years) on 4 days: (1) control (no drug); (2) meperidine (target plasma level 0.3 microg/mL); (3) dexmedetomidine (target plasma level 0.4 ng/mL); and (4) meperidine plus dexmedetom..View full abstract
Awarded by NIGMS NIH HHS